2014 Archive

December 22, 2014

McGrath   Thadhani

Brigham Board Review Course    Boston, MA; August, 2013 Hematuria - Board Review Martina M. McGrath, MD Pregnancy and Renal Disease Ravi Thadhani, MD

Esezobor   Onuigbo   Gupta   Daugirdas

Advances in CKD 2014 (PART 8)    Renal Research Institute Las Vegas, NV; January, 2014 PART EIGHT Peritoneal Dialysis for Children with AKI in Nigeria: Saving Young Lives with Improvisations Christopher Esezobor, MD CKD Predictions and Concepts of progresses and non-progresses Macaulay Onuigbo, MD Circulating Fibroblast Growth Factor-2 (FGF-2) induces proteinuria and glomerular injury in young mice Charu Gupta, MD Keynote Address: A Different Approach to the Dialysis Prescription John Daugirdas, MD

October 31, 2014

Misra   Ding   Gura   Chen   Canaud   Huang   Jo   Yu   Marshall

ISHD Hemodialysis University™ 2013 Shanghai Update (PARTS 5 through 9)    International Society for Hemodialysis Shanghai, China; April, 2013 Part 9 Blood Pressure on Dialysis: Salt volume, RRF and beyond Madhukar Misra, MD Anemia in Hemodialysis Patients Andrew Davenport, MD Part 8 The Artificial wearable Kidney - Status Victor Gura, MD Infection control in the Hemodialysis Unit Victor Gura, MD Anemia in Hemodialysis Patients Hung-Chun Chen, MD Part 7 When to initiate Dialysis: Early or Late and Why? Bernard Canaud, MD Timing and dose of RRT in Acute Kidney Injury Mark R Marshall, MD Part 6 Hepatitis in hemodialysis patients Chiu-Chin Huang, MD Immune dysfunction in HD patients Sang Kyung Jo, MD Part 5 Choice in Dialysis Modality Xueqing Yu MD RRT in Acute Kidney Injury: A comparative overview of available therapies Mark R Marshall, MD

Dember

Brigham Board Review Course    Boston, MA; August, 2013 Paraprotein Related Kidney Diseases Laura M. Dember, MD

Appel   Betjes   Ghaffari   Kuhlmann

Advances in CKD 2014 (PART 7)    Renal Research Institute Las Vegas, NV; January, 2014 PART SEVEN Progression of CKD: The role of APOL1 and other recent advances Oral Anticoagulation in Advanced Kidney Disease Lawrence J. Appel, MD Smouldering immunologic derangements in ESRD. What are the implications? Michiel G.H. Betjes, MD Urgent-Start PD: Patient benefits or financial incentives? Arshia Ghaffari, MD Is the Mediterranean diet better than the current approach of protein restriction in pre dialysis CKD? Martin Kuhlmann, MD

September 4, 2014

Ding   Kerr   Itami   Canaud   Urbanes

ISHD Hemodialysis University™ 2013 Shanghai Update (PARTS 3 and 4)    International Society for Hemodialysis Shanghai, China; April, 2013 PART FOUR Uremic toxins: An Overview and Update Xiao-qiang Ding, MD Maximizing the benefits of HD: More long or more frequent Peter G Kerr, MD Application and clinical effect of CDDS in Japan Noritomo Itami, MD PART THREE Basics of Water Quality in the Hemodialysis unit Peter G Kerr , MD Hemodialysis Adequacy in 2013 Bernard Canaud, MD Taming the beast: Chronic Hemodialysis Cather Aris Q Urbanes, MD

Suri   Hammond

Brigham Board Review Course    Boston, MA; August, 2013 Home Dialysis Cases Rita Suri, MD Infections in Immunocompromised Hosts Sarah P. Hammond, MD

Zoccali   Pecoits-Filho   McIntyre   Aliotta

Advances in CKD 2014 (PART 6)    Renal Research Institute Las Vegas, NV; January, 2014 PART SIX Subclinical thyroid dysfunction and clinical outcomes in end stage kidney disease Carmine Zoccali, MD Debate: Endotoxemia in CKD is primarily a fluid overload phenomenon   Yes: Roberto Pecoits-Filho, MD   No: Chris W. McIntyre, MD Regenerative medicine - What are the prospects in nephrology? Jason M. Aliotta, MD

June 30, 2014

Misra   Ding   Cai   Davenport   Li   Urbanes

ISHD Hemodialysis University™ 2013 Shanghai Update (PARTS 1 and 2)    International Society for Hemodialysis Shanghai, China; April, 2013 Parts ONE and TWO ISHD Hemodialysis University, Shanghai Update: Opening Ceremony Madhukar Misra, MD (ISHD President and Course Co-Director) and Ding Xiaoqiang, MD, PhD, (Course Co-Director) Prof. Liao Lutan’s Lifetime Achievement Award Madhukar Misra, MD Essentials of a hemodialysis machine: What does a nephrologist need to know? Madhukar Misra, MD Dialysis in China: Current status and Challenge Guang-yan Cai MD Dialysate Sodium in HD: What is important to know? Andrew Davenport MD Dialyzer Membrane Permeability: Effect on Cardiovascular Outcome Philip Li, MD Getting it right: Planning, Monitoring, and Maintaining the Dialysis AVF Aris Q Urbanes, MD

Christopher

Brigham Board Review Course    Boston, MA; August, 2013 CVVH for the Boards Kenneth B. Christopher, MD

Levin   Collins   Unruh   McIntyre   Cochat   Grantham

Advances in CKD 2014 (PARTS 4 and 5)    Renal Research Institute Las Vegas, NV; January, 2014 Parts FOUR and FIVE CKD progression predictors in 2014 Adeera Levin, MD Epidemiology of dialysis withdrawal Allan J. Collins, MD Are the current ethical standards for dialysis withdrawal adequate? Mark Unruh, MD Keynote Address: Brain damage in pre-dialysis CKD, HD, and PD Chris W. McIntyre, MD The issue of the solitary kidney Pierre Cochat, MD Recent advances in polycystic kidney disease research with emphasis on therapy Jared Grantham, MD

May 31, 2014

Yu	Brigham Board Review Course    Boston, MA; August, 2013 Electrolytes and Acid Base Practice for the Boards Alan S.L. Yu, MD

Maduell   Ketchersid   Titze   Zoccali   Power

Advances in CKD 2014 (PARTS 2 and 3)    Renal Research Institute Las Vegas, NV; January, 2014 Part TWO Three RCTs in HDF: A critical analysis and implications for future use Francisco Maduell, MD “Big Data” in nephrology: friend or foe? Terry Ketchersid, MD Keynote Address: Non-osmotic sodium storage as a pathogenetic factor in hypertension in CKD & ESRD Jens Titze, MD PART THREE Lung congestion as a risk factor in end stage renal disease Carmine Zoccali, FASN Stroke in Dialysis and CKD Albert Power, MD

April 30, 2014

Appel

Brigham Board Review Course    Boston, MA; August, 2013 IgA Nephropathy Gerald A. Appel, MD

Kotanko   Weintraub   Ok   Nissenson

Advances in CKD 2014 (PART 1)    Renal Research Institute Las Vegas, NV; January, 2014 Welcome Peter Kotanko, MD The spectrum of CKD - a patient’s journey Judy Weintraub, MS Ed The balance between dialysis duration and sodium restriction in volume control Ercan Ok, MD Accountable Care Organizations and ESRD Allen R. Nissenson, MD

Kuritzky   Bakris   Basile   Ferdinand   Deedwania   Iadecola

American Society of Hypertension Annual Scientific Meeting (Parts 16-21 )    San Francisco, CA; May 2013 MANAGEMENT ISSUES IN HYPERTENSION: TRICKS OF THE TRADE Hypertension Urgencies and Emergencies Louis Kuritzky, MD HYPERTENSION FOR THE PRIMARY CARE CLINICIAN 2013 Case-1: Discussion George L. Bakris, MD, Jan N. Basile, MD, and Keith C. Ferdinand, MD Case-2: Discussion George L. Bakris, MD, Jan N. Basile, MD, and Keith C. Ferdinand, MD NEW CONSIDERATIONS IN DYSLIPIDEMIA AND CARDIOMETABOLIC DISORDERS Management of Dyslipidemias in Patients with Hypertension, Diabetes and Metabolic Syndrome Prakash C. Deedwania, MD VASCULAR WALL SIGNALING: HOW ARE CELLS COUPLED? Endothelin Role in Neurovascular Regulation and Dysregulation Costantino Iadecola, MD BLOOD PRESSURE TARGETS FOR PRIMARY CARE What Should Be the Initial Pharmacologic Therapy Barry L. Carter, PharmD LATE BREAKING CLINICAL TRIALS Cardiovascular Effects Based on Magnitude of WL in Obese/Overweight Subjects with Hypertension Receiving Phentermine and Topiramate Extended-Release George Bakris, MD

March 31, 2014

Ram   Calhoun   White   Yarows   Viera   Mizuno   Flynn   Oparil   Basile   Bakris

American Society of Hypertension Annual Scientific Meeting (Parts 11-15 )    San Francisco, CA; May 2013 Part 15. PLENARY SESSION Marvin Moser Clinical Hypertension Award Lecture - Treatment of Hypertension: From Drugs to Devices C. Venkata S. Ram, MD Part 14. NOCTURNAL BP The Treatment of Hypertension Should be Targeted Towards the Nocturnal Blood Pressure - Antagonist David A. Calhoun, MD Part 13. HOME BP AND AMBULATORY BP MONITORING Home and Ambulatory Blood Pressure Monitoring: Review of the ASH Position Paper William B. White, MD Implementing ABPM into Your Practice Steven A. Yarows, MD Interpreting the Data in Adult and Pediatric Populations: A Case-Based Approach Anthony J. Viera, MD Part 12. SPECIAL POPULATIONS The Asian Hypertensive Eric T. Mizuno, MD Adolescents with Hypertension Joseph T. Flynn, MD Part 11. UPDATE ON RESISTANT HYPERTENSION Resistant Hypertension: Incidence, Prevalence, and Pathophysiology Suzanne Oparil, MD Patient Case: The Resistant Hypertensive Patient Who Remains Uncontrolled Jan N. Basile, MD Symplicity HTN-3 and Resistant Hypertension George L. Bakris, MD

February 26, 2014

Flack   Taylor   Weir   Cushman   Taler   Agarwal   Woo   Steinberger   Carter   Marrs   Arnett   Meyer   Wesson   Textor

American Society of Hypertension Annual Scientific Meeting (Parts 6-10 )    San Francisco, CA; May 2013 PART 6 WITHIN-CLASS DIFFERENCES IN ANTIHYPERTENSIVE THERAPIES The Diuretics John M. Flack, MD The Beta Blockers Addison A. Taylor, MD The ACE Inhibitors and ARBs Matthew R. Weir, MD PART 7 WHAT SHOULD TARGET BLOOD PRESSURE BE? Con: What Should the Target Blood Pressure Be in Diabetic Patients? 130/80 is the Goal William C. Cushman, MD Pro: What Should the Target Blood Pressure Be in CKD Patients? 130/80 is the Goal Sandra J. Taler, MD Con: What Should the Target Blood Pressure Be in CKD Patients? 130/80 is the Goal Rajiv Agarwal, MD PART 8 CHILDHOOD COHORTS: WHAT CAN THEY TEACH US ABOUT ADULT HYPERTENSION AND CARDIOMETABOLIC DISEASE? Princeton School Study and NHLBI Growth and Health Study: Obesity and Secular Trends in Blood Pressure Jessica G. Woo, PhD Minneapolis Blood Pressure Studies: Insulin Resistance and Blood Pressure Julia Steinberger, MD PART 9 ELEMENTS OF RESISTANT HYPERTENSION: A FOCUS ON PHARMACOKINETICS AND PHARMACODYNAMICS Assessment of Adherence Barry L. Carter, PharmD Methods for Improving Adherence Joel C. Marrs, PharmD Use of Generic Medications in Resistant Hypertension Rhonda Cooper-DeHoff, PharmD Pharmacogenetic Factors in Blood Pressure Control Donna K. Arnett, PhD PART 10 BEYOND BLOOD PRESSURE: PROTECTING THE KIDNEY Uremic Toxicity Timothy W. Meyer, MD Alkali Therapy Donald Wesson, MD Hypoxia as the Common Pathway to Nephron Loss Steven C. Textor, MD

January 31, 2014

Niles

Brigham Board Review Course    Boston, MA; August, 2012 Rapidly Progressive Glomerulonephritis, Parts 1 and 2 John Niles, MD

Bergman   Oparil   Sandoval   Iadecola   Calhoun   Coooper   Pohl   Weir   Bakris

American Society of Hypertension Annual Scientific Meeting (Parts 2-5 )    San Francisco, CA; May 2013 OBESITY AND CARDIOMETABOLIC DISEASES Adipocytes as Regulators of Metabolic Balance Richard N. Bergman, PhD Pharmacologic Treatments for Obesity Suzanne Oparil, MD (audio only) Bariatric Surgery: Metabolic and Blood Pressure Effects Darleen Sandoval, PhD HYPERTENSION: A MULTISYSTEM DISEASE Brain and Hypertension Costantino Iadecola, MD NEW CONCEPTS IN THE MANAGEMENT OF REFRACTORY HYPERTENSION AND RENAL ARTERY STENOSIS Diagnostic Approach and Treatment of Resistant Hypertension David A. Calhoun, MD Atherosclerotic Renal Artery Stenosis: Where Do We Go if CORAL is a Negative Trial? Christopher J. Cooper, MD Renal Fibromuscular Dysplasia Marc A. Pohl, MD (audio only) HYPERKALEMIA AND HYPERTENSION: NEW CONSIDERATIONS Cardio-Renal Risk Reduction and Potassium Management in the Hypertensive Patient Matthew R. Weir, MD Management Strategies for Elevated Potassium Levels and Cardiovascular Outcomes George L. Bakris, MD

Urbanes   Lok   May   Hentschel   Illig   Samaha   Fox   Haskal   Rajan   Lee   Lawson   Peden   Pflederer   Blaser   Wasse   Veseley     Falk

ASDIN Annual Scientific Meeting (Parts 11-19)    Washington, DC; February, 2013 PART 11 New Initiatives for ASDIN Affiliation and Collaboration Aris Urbanes, MD Vascular access procedures and infection: time for evidence-based policy Charmaine Lok, MD Developing Internventional Nephrology in Australia/New Zealand Stephen May, MD PART 14 ACCESS COMPLICATIONS: High Flow AVFs Recognition and Diagnosis of high-flow fistula Dirk Hentschel, MD Surgical treatment options for the "Mega-AVF" Karl A. Illig, MD Endovascular treatment options for the "Mega-AVF" Tony Samaha, MD PART 15 ACCESS COMPLICATIONS: Point/Counterpoint First line Treatment of Peripheral Vein Stenosis Should be With a Covered Stent Ziv J. Haskal MD Don’t Stent: Surgical Management is Best David Fox, MD Symptomatic Central Venous Obstruction is Best Treated with PTA and Stenting Dheeraj K. Rajan MD Surgical Treatment is The Optimal for Symptomatic Central Venous Obstruction Karl A. Illig, MD PART 17 ADVANCES IN AV ACCESS Arterial Elasticity and AVF maturation William D. Paulson, MD Pre-existing Vascular Calcification and AVF Maturation Timmy Lee, MD Tissue-engineered vascular grafts Jeffrey H. Lawson, MD Optiflow Vascular Anastomosis Device Eric K. Peden, MD Extending Access Site Patency with Novel Devices Jeffrey H. Lawson, MD PART 18 REALITY CHECK: BUSINESS AND POLICY OF AV ACCESS Drug Shortages Aris Q. Urbanes, MD True Lies: Ethical Behavior when patient has not received optimal care Timothy A. Pflederer, MD Intersection of Regulatory Bodies Robert Blaser, MD The Economics of Fistula First Timothy A. Pflederer, MD Interventional Nephrology and the Accountable Care Organization Model Robert Blaser, MD Closing Remarks and Adjournment Haimanot Wasse, MD PART 19 NON-DIALYSIS PROCEDURES and TECHNIQUES Port Placement, removal and Management Thomas Vesely, MD (handout only) IVC Filter: Indications, Placement, Complications Dheeraj Rajan, MD (handout only) Varicose Vein Therapy: An introduction to Surgical and Endovascular Treatment Abigail Falk, MD (handout only)

Annual Dialysis Conference 2013 now in MP3

AUDIOFILE LIST (Annual Dialysis Conference 2013) Special Situations in PD Jean Holley, MD, and Joshua Botdorf, DO Clinical and Administrative Issues: Quality Outcomes in Nephrology Katrina Russell, RN, Jay Wish, MD, Caprice Vanderkolk, MS, RN, and Debbie Cote, MSN, RN The Hypertensive Overhydrated Patient: Making Sense of Different Strategies Peter Kotanko, MD, Bernard Canaud, MD, Ercan Ok, MD, and Christopher Chan, MD PD Nursing Clinical Topics V Elizabeth Kelman, MEd, RN, Ann Marie Correia, ASN, RN, Barbara Valle, BSN, RN, and Lisa Sotter, BSN, RN Nutrition and Metabolism Steven Guest, MD, Jean Holley, MD, Gautam Phadke, MD, and Georges Saab, MD Persistent Challenges in Dialysis Therapies: Has There Been Progress? Joanne Bargman, MD, and William Clark, MD PD and HD Dialysis Catheters: Implantation and Care W. Kirt Nichols, MD, John Crabtree, MD, Michael Tal, MD, and Anil Agarwal, MD

HDCN home /about our site / subscribe to key zone / register for free zone
update email address / subscription status / forget your password?